Michael Kaltenborn

Chief Strategy And Corp Dev. Officer (csdo) at Karo Healthcare

Michael Kaltenborn is an experienced executive currently serving as the Chief Strategy and Corporate Development Officer at Karo Healthcare since February 2023, where responsibilities include Strategy, Business Development & Licensing, M&A, Separation/Integration, and Legal in a digitally first Fast Moving Consumer Healthcare platform. Previously, Kaltenborn spent over 15 years at Bayer, culminating in the role of Global Head of M&A for Consumer Health, leading global M&A activities for one of the world's top consumer health companies and acting as America's Hub Leader for BD&L, M&A, and Separation & Integration. Earlier career experience includes a managerial role at EY from 2002 to 2007 and a graduate education culminating in a Master's degree in Business Administration from the University of Münster, complemented by further studies at IMD from 2017 to 2020.

Links